Lacosamide Injection
Product Images NDC 69367-352

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 69367-352). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Westminster Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Structure (Lacosamide 01)

Chemical Structure (Lacosamide 01)
FDA Label Image

Figure 1 (Lacosamide 02)

Figure 1 (Lacosamide 02)
This text provides information on seizure reduction percentages for two medications, Lidia and Pasphe Lacams. It shows the median percentage change from baseline for each medication, which is 20% for Lidia and 15% for Pashbe Lacoms. Additionally, there are numerical values for each medication group and indicates a statistically significant difference between the two compared treatments.*
FDA Label Image

Figure 2 (Lacosamide 03)

Figure 2 (Lacosamide 03)
This appears to be a tabular representation showing responder rates, improvements, and worsenings for different dosages of lacosamide alongside a placebo. The table includes percentages corresponding to each category for different dosages of lacosamide (200mg/day, 400mg/day, 600mg/day) compared to a placebo. Each percentage value indicates the proportion of patients who showed a response, improvement, or worsening under each treatment condition.*
FDA Label Image

Figure 3 (Lacosamide 04)

Figure 3 (Lacosamide 04)
FDA Label Image

Principal Display Panel (20 mL Vial Carton)

Principal Display Panel (20 mL Vial Carton)
Manufactured by: OP RanoPharma Co. Ltd. Manufactured for: Westminster Pharmaceuticals LLC This text provides details about Lacosamide Injection, USP, including its dosage and usage instructions. It specifies the manufacturer and the pharmaceutical company it is manufactured for. The medication guide for patients is recommended to be dispensed separately by the pharmacist. The product is available in 10 x 20 mL single-dose vials for intravenous use only.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.